Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-064283·ABVC BIOPHARMA, INC.
Schedule 13D ownership disclosure
ABVC BIOPHARMA INC
Common Stock, par value $0.001 per share · CUSIP: 00091F304
Event date: 2025-07-10
- Filing-level shares
- 131,159.00
- Percent of class
- 18.50%
- Eugene JiangReported CIK 0001892728
Shares: 131,159.00 · Class: 18.50%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-064283
- Form type
- SCHEDULE 13D/A
- Filer
- ABVC BIOPHARMA, INC.
- CIK
- CIK 1173313
- Filed
- Jul 15, 2025
- Reporting period
- Jul 10, 2025
- Description
- Schedule 13D beneficial ownership